MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

Search

IDEXX Laboratories Inc

Closed

Sector Healthcare

452.82 0.04

Overview

Share price change

24h

Current

Min

452.08

Max

458.03

Key metrics

By Trading Economics

Income

233M

Sales

-21M

954M

P/E

Sector Avg

42.188

73.394

EPS

2.62

Profit margin

23.868

Employees

11,000

EBITDA

-76M

262M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+14.53 upside

Dividends

By Dow Jones

Next Earnings

30 Apr 2025

Market Stats

By TradingEconomics

Market Cap

1.7B

37B

Previous open

452.78

Previous close

452.82

News Sentiment

By Acuity

27%

73%

60 / 393 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

IDEXX Laboratories Inc Chart

Past performance is not a reliable indicator of future results.

Related News

2 May 2024, 17:43 UTC

Earnings

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 May 2024, 13:06 UTC

Earnings

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

Peer Comparison

Price change

IDEXX Laboratories Inc Forecast

Price Target

By TipRanks

14.53% upside

12 Months Forecast

Average 518.57 USD  14.53%

High 550 USD

Low 460 USD

Based on 7 Wall Street analysts offering 12 month price targets forIDEXX Laboratories Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

7 ratings

4

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

451.89 / 459.78Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Very Strong Bullish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

60 / 393 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About IDEXX Laboratories Inc

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.